Upregulation of KIF20A has been demonstrated in numerous types of cancer, and is an independent prognostic factor for poor clinical outcomes for early-stage cervical squamous cell carcinoma, glioma and breast cancer (46–48). Here, KIF20A is linked to cervical squamous cell carcinoma.